Leidos | Jotup

TFF Pharmaceuticals and Leidos to Advance Next-Generation Biodefense Countermeasures Under the DARPA PPB Program into Preclinical Testing

Retrieved on:

Jeudi, mai 23, 2024

Military personnel, DARPA, Science, Leidos, Government, Engineering, Research, Face, PPB, TFF, Fortune 500, Microsoft, Temperature, Vaccine

FORT WORTH, Texas, May 23, 2024 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP) (“the Company”), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform, today announced that the government will be advancing several next-generation medical countermeasures (MCMs) formulated with its Thin Film Freezing technology into advanced preclinical testing. TFF Pharmaceuticals is collaborating with Leidos, a leading Fortune 500 information technology, engineering and science solutions and services leader, to develop next-generation MCMs designed to protect military and healthcare personnel against future chemical and biological (CB) threats. The research is funded by the Defense Advanced Research Projects Agency (DARPA) under a contract through the Personalized Protective Biosystems (PPB) program.

Key Points:

TFF Pharmaceuticals is collaborating with Leidos, a leading Fortune 500 information technology, engineering and science solutions and services leader, to develop next-generation MCMs designed to protect military and healthcare personnel against future chemical and biological (CB) threats.
The research is funded by the Defense Advanced Research Projects Agency (DARPA) under a contract through the Personalized Protective Biosystems (PPB) program.
The candidate MCMs delivered by Leidos to TFF Pharmaceuticals have been successfully formulated utilizing the Company’s proprietary Thin Film Freezing technology platform.
The MCMs are now progressing into in vivo preclinical testing, which will be conducted at DARPA-contracted laboratories.

Leidos Holdings, Inc. Reports First Quarter Fiscal Year 2024 Results

Retrieved on:

Mardi, avril 30, 2024

EPS, DSO, GAAP, Accounting, Health, Leidos

Management believes that these non-GAAP measures provide another measure of Leidos' results of operations and financial condition, including its ability to comply with financial covenants.

Key Points:

Management believes that these non-GAAP measures provide another measure of Leidos' results of operations and financial condition, including its ability to comply with financial covenants.
Revenues for the quarter were $3.98 billion, up 7% compared to the first quarter of 2023.
As of March 29, 2024, Leidos had $633 million in cash and cash equivalents and $4.7 billion of debt.
Leidos is updating its fiscal year 2024 guidance as follows:

Leidos Holdings, Inc. Declares Quarterly Cash Dividend

Retrieved on:

Vendredi, avril 26, 2024

Leidos, LDOS

RESTON, Va., April 26, 2024 /PRNewswire/ -- Leidos Holdings, Inc. (NYSE:LDOS) today announced that its Board of Directors has declared a quarterly cash dividend of $0.38 per outstanding share of common stock of Leidos Holdings, Inc.

Key Points:

RESTON, Va., April 26, 2024 /PRNewswire/ -- Leidos Holdings, Inc. (NYSE:LDOS) today announced that its Board of Directors has declared a quarterly cash dividend of $0.38 per outstanding share of common stock of Leidos Holdings, Inc.
The cash dividend is payable on June 28, 2024, to stockholders of record as of the close of business on June 14, 2024.

iBase-t Announces Customer Brilliance Award Winners at Excelerate 2024

Retrieved on:

Jeudi, mars 21, 2024

LAKE FOREST, Calif., March 21, 2024 /PRNewswire/ -- iBase-t, the company that simplifies how complex products are built and maintained, announced this year's recipients of its Customer Brilliance Awards, which celebrate the unique strategies customers in complex manufacturing industries have put in place to successfully drive innovation and evolution in their digital manufacturing, quality and MRO sustainment operations with iBase-t.

Key Points:

The awards were presented at the company's business and user conference, Excelerate , which took place March 11-14, 2024 in Newport Beach, California.
Excelerate offers a stage for the best and brightest to demonstrate their success, share ideas, learn from one another, and ultimately, drive innovation across the industry through Solumina."
iBase-t Customer Brilliance Award Winners:
Leidos has demonstrated outstanding commitment to the success of their Solumina platform as well as the company's dedication to maintaining the highest standards of quality and excellence across their organization.
Northrop Grumman demonstrated the strength of leadership to enforce an out-of-the-box deployment when business processes can be difficult to change.

MultiPlan Appoints Jerry Hogge as Chief Operating Officer

Retrieved on:

Jeudi, mars 7, 2024

MultiPlan Corporation (NYSE: MPLN) (“MultiPlan” or the “Company”), a leading value-added provider of data analytics and technology-enabled end-to-end cost management, as well as payment and revenue integrity solutions to the U.S. healthcare industry, today announced that Jerry Hogge will join the Company as Executive Vice President, Chief Operating Officer (COO).

Key Points:

MultiPlan Corporation (NYSE: MPLN) (“MultiPlan” or the “Company”), a leading value-added provider of data analytics and technology-enabled end-to-end cost management, as well as payment and revenue integrity solutions to the U.S. healthcare industry, today announced that Jerry Hogge will join the Company as Executive Vice President, Chief Operating Officer (COO).
Hogge is a highly accomplished operational and commercial leader who has excelled within the healthcare and telecommunications industries for over 30 years.
Hogge most recently served as Executive Vice President and Chief Operations Officer at CALIBRE Systems Inc. where he was responsible for both revenue growth and company operations.
“I couldn’t be more delighted and honored to be a part of the MultiPlan team, and I look forward to working alongside the 2,800 professionals that have made the company such a great success.” said Hogge.

Arine Accelerates Growth, Expands Board of Directors

Retrieved on:

Mardi, février 13, 2024

SAN FRANCISCO, Feb. 13, 2024 /PRNewswire/ -- Arine, an AI-driven SaaS platform company focused on medication intelligence, today announced significant growth in its customer base as well as three additions to its Board of Directors who bring deep leadership experience spanning the health and SaaS industries. These executives will partner with Arine in enabling an expanding number of health plans and risk-based providers, through the application of Arine's software platform, to deliver reductions in total cost of care and improved patient outcomes. Arine's software is currently implemented by a broad set of health insurers, addressing medication related problems at scale and helping these organizations to quickly drive improved care for their millions of members.

Key Points:

The Board expansion comes at a time of accelerated growth for the organization.
Arine has achieved a remarkable 100% client retention rate since inception and increased its revenue by 100% in 2023.
In total, the company's AI-driven platform has produced more than 33 million life-improving recommendations and touched over 15 million client members.
Cassels began his career with the Advisory Board Company where he was a founding partner in the firm's Strategy Consulting practice.

Leidos Holdings, Inc. Reports Fourth Quarter and Fiscal Year 2023 Results

Retrieved on:

Mardi, février 13, 2024

Health, EPS, GAAP, DSO, Leidos, Bank

For the quarter, net income was $230 million, or $1.66 per diluted share, up 28% and 30%, respectively, compared to the fourth quarter of fiscal year 2022.

Key Points:

For the quarter, net income was $230 million, or $1.66 per diluted share, up 28% and 30%, respectively, compared to the fourth quarter of fiscal year 2022.
Non-GAAP net income was up 8%, and non-GAAP diluted EPS was up 9% compared to the fourth quarter of fiscal year 2022.
Days Sales Outstanding (DSO) for the quarter was 56, a 1-day improvement from the third quarter of 2023 and a 2-day improvement from the fourth quarter of fiscal year 2022.
Net bookings totaled $2.8 billion in the fourth quarter of fiscal year 2023 and $16.5 billion for fiscal year 2023, representing book-to-bill ratios of 0.7 and 1.1, respectively.

Leidos Holdings, Inc. Declares Quarterly Cash Dividend

Retrieved on:

Jeudi, février 8, 2024

LDOS, Leidos

RESTON, Va., Feb. 8, 2024 /PRNewswire/ -- Leidos Holdings, Inc. (NYSE: LDOS) today announced that its Board of Directors has declared a quarterly cash dividend of $0.38 per outstanding share of common stock of Leidos Holdings, Inc.

Key Points:

RESTON, Va., Feb. 8, 2024 /PRNewswire/ -- Leidos Holdings, Inc. (NYSE: LDOS) today announced that its Board of Directors has declared a quarterly cash dividend of $0.38 per outstanding share of common stock of Leidos Holdings, Inc.
The cash dividend is payable on March 28, 2024, to stockholders of record as of the close of business on March 15, 2024.

Maximus Names Derrick Pledger New Chief Digital and Information Officer

Retrieved on:

Mardi, janvier 30, 2024

Maximus (NYSE: MMS), a leading employer and provider of government services worldwide, today announced Derrick Pledger has been named Chief Digital and Information Officer (CDIO).

Key Points:

Maximus (NYSE: MMS), a leading employer and provider of government services worldwide, today announced Derrick Pledger has been named Chief Digital and Information Officer (CDIO).
View the full release here: https://www.businesswire.com/news/home/20240130228520/en/
Derrick Pledger, Chief Digital and Information Officer of Maximus (Photo: Business Wire)
“Derrick brings a wealth of experience to Maximus as a noted leader in technology modernization and strategic leadership, and we are excited about adding those skills to our talented executive team,” said Bruce Caswell, President and CEO of Maximus.
This new role is a tremendous opportunity to join a growing team and lead it to even greater heights,” said Pledger.
Reflecting his commitment to talent development, Pledger recently implemented a broad upskilling program for CDIO personnel in analytics, cloud, and AI.

Quantum Computing Inc. Board of Directors Appoints Dr. William McGann as the Company's CEO and Co-Founder Robert Liscouski as Chairman of the Board

Retrieved on:

Mercredi, janvier 31, 2024

William (Bill) J. McGann, Ph.D., a globally recognized leader in commercialization of innovative technology, has been appointed CEO of Quantum Computing Inc. Dr. McGann succeeds QCi's co-founder Robert Liscouski who remains Chairman of the Board to help oversee the Company's growth and expansion.

Key Points:

William (Bill) J. McGann, Ph.D., a globally recognized leader in commercialization of innovative technology, has been appointed CEO of Quantum Computing Inc. Dr. McGann succeeds QCi's co-founder Robert Liscouski who remains Chairman of the Board to help oversee the Company's growth and expansion.
Dr. McGann has a decade-long track record for transforming credible science into practical technology in steps of innovation, engineering, and leadership.
Bill and the team are leading the charge in the Company's mission to provide "accessible and affordable" quantum technology to the world.
Commenting on Dr. McGann's appointment, Robert Liscouski, co-founder and Chairman of Quantum Computing Inc., shared, "Over the past six years, QCi has evolved into an innovative leader of nanophotonic quantum technologies.